| Acumen Pharmaceuticals (NASDAQ:ABOS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $4.00 price target on the stock. This represents a 236.1% upside from the current price of $1.19. |
| Arcellx (NASDAQ:ACLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $110.00 price target on the stock. This represents a 71.8% upside from the current price of $64.05. |
| Amylyx Pharmaceuticals (NASDAQ:AMLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock. This represents a 119.4% upside from the current price of $5.47. |
| Artivion (NYSE:AORT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 20.9% upside from the current price of $28.96. |
| ASML (NASDAQ:ASML) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $806.00 price target on the stock. This represents a 5.6% upside from the current price of $763.52. |
| BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $49.00 price target on the stock. This represents a 20.5% upside from the current price of $40.67. |
| Coinbase Global (NASDAQ:COIN) is now covered by analysts at China Renaissance. They set a "buy" rating and a $353.30 price target on the stock. This represents a 37.7% upside from the current price of $256.49. |
| EOG Resources (NYSE:EOG) is now covered by analysts at Stephens. They set an "equal weight" rating and a $137.00 price target on the stock. This represents a 9.3% upside from the current price of $125.34. |
| EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 202.1% upside from the current price of $9.27. |
| Flotek Industries (NYSE:FTK) is now covered by analysts at Northland Securities. They set a "market perform" rating and a $16.00 price target on the stock. This represents a 3.6% upside from the current price of $15.44. |
| Galectin Therapeutics (NASDAQ:GALT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $6.00 price target on the stock. This represents a 239.6% upside from the current price of $1.77. |
| Mayville Engineering (NYSE:MEC) is now covered by analysts at DA Davidson. They set a "buy" rating and a $23.00 price target on the stock. This represents a 50.6% upside from the current price of $15.27. |
| monday.com (NASDAQ:MNDY) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $330.00 price target on the stock. This represents a 16.8% upside from the current price of $282.47. |
| NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 114.7% upside from the current price of $19.56. |
| Nordson (NASDAQ:NDSN) is now covered by analysts at Vertical Research. They set a "hold" rating and a $245.00 price target on the stock. This represents a 12.0% upside from the current price of $218.68. |
| Neurogene (NASDAQ:NGNE) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $50.00 price target on the stock. This represents a 159.7% upside from the current price of $19.26. |
| Novavax (NASDAQ:NVAX) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $6.00 price target on the stock. This represents a 11.2% downside from the current price of $6.76. |
| PTC Therapeutics (NASDAQ:PTCT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $80.00 price target on the stock. This represents a 54.5% upside from the current price of $51.76. |
| Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $72.00 price target on the stock. This represents a 31.8% upside from the current price of $54.63. |
| Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $55.00 price target on the stock. This represents a 78.9% upside from the current price of $30.74. |
| SAP (NYSE:SAP) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.The current price is $295.37. |
| Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $22.08. |
| Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Jones Trading. They set a "buy" rating and a $24.00 price target on the stock. This represents a 124.5% upside from the current price of $10.69. |
| Venture Global (NYSE:VG) is now covered by analysts at Johnson Rice. They set a "buy" rating and a $20.00 price target on the stock. This represents a 15.7% upside from the current price of $17.29. |
Ratings changes for SolarEdge Technologies, Enphase Energy, Sunrun, NVIDIA, Cooper Companies, monday.com, TransMedics Group and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
